Dr. Eslam Abdo is a pharmacist with a clinical pharmacy background and a senior regulatory and health technology assessment professional with extensive experience across pharmaceutical, biologic and medical-device regulation. He currently serves as Senior Analyst – Drug and Medical Product Regulations at the Department of Health – Abu Dhabi, where he leads medical product assessment, coding, pricing and reimbursement reviews and contributes to the development of health regulations, standards and policies.
He is a former member of the Health Technology Assessment Taskforce and regularly represents the Department of Health at regional and international conferences. Previously, he served as a Regulatory Affairs Specialist at the Ministry of Health and Prevention (MOHAP), UAE, with responsibilities spanning pharmaceutical registration, eCTD dossier review, biologics and biosimilar evaluation, COVID-19 vaccine assessment, emergency use authorizations, drug pricing and national regulatory-system strengthening in collaboration with the World Health Organization.
His expertise also includes regulatory legislation, GMP/GCP auditing, health technology assessment, market access and alignment with global regulatory frameworks including FDA and EMA, with a strong focus on patient safety, evidence-based decision-making and sustainable healthcare systems.